clottafact 1.5 g/100 ml injection
al ittihad drug store france - powder in a vial (glass) + 100 ml of solvent in a vial (glass) with a stopper (halobutyl) - injection - 1.5 g/100 ml - cardiovascular system-antifibrinolytics , haemostatics
probeta n drops 105 mg/100ml + 0.525 mg/100ml
atco laboratories limited, pakistan - betamethasone , antibiotics - drops - 105 mg/100ml + 0.525 mg/100ml
metronidazole iv 500mg/100ml (gulf inject)
100 ml ldpe bottle -
xarocen ® 200 mg/100 ml
100 ml bag -
prof® 400 mg per 100 ml 400 mg/ 100 ml infusion
alphamed drug store saudi arabia - 100 ml glass bottle - infusion - 400 mg/ 100 ml - musculoskeletal ,joint diseases-rheumatic diseases , gout
levetiracetam juno levetiracetam 500mg/100ml solution for infusion bags
horizon hospital healthcare pty ltd - levetiracetam -
epirube epirubicin hydrochloride 200 mg/100 ml concentrated injection vial
teva pharma australia pty ltd - epirubicin hydrochloride -
epirubicin accord epirubicin hydrochloride 200mg/100ml concentrated injection vial
accord healthcare pty ltd - epirubicin hydrochloride, quantity: 200 mg - injection, concentrated - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - epirubicin has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/ metastatic soft tissue sarcoma, superficial bladder cancer (tis; ta). in bladder cancer, epirubicin is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grades 2 and 3).
ropivacaine sandoz ropivacaine hydrochloride (as monohydrate) 200mg/100ml solution for injection infusion bag
sandoz pty ltd - ropivacaine hydrochloride, quantity: 2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid; sodium chloride - surgical anaesthesia (adults and children over 12 years of age). - epidural block for surgery including caesarean section. - intrathecal anaesthesia. - field block (minor nerve block and infiltration). - major nerve block. analgesia (adults and children over 12 years of age). - continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. - field block (minor nerve block and infiltration). - continuous peripheral nerve block infusion or intermittent injections for post operative pain management. analgesia (children aged 0 - 12 years). - caudal epidural block in neonates (> 37 weeks gestation and over 2500 g weight), infants and children up to and including 12 years . - continuous epidural infusion in infants (> 30 days and over 2500 g weight) and children up to and including 12 years. - peripheral nerve block in children aged 1 up to and including 12 years. for peri- and postoperative pain management. there are no safety or efficacy data to support the use of ropivacaine for analgesia for longer than 72 hours. (data for peripheral nerve block administered as a continuous peripheral infusion or intermittent injections support the use for up to 48 hours only).
fluconazole alphapharm fluconazole 200 mg/100 ml solution for infusion bag
alphapharm pty ltd - fluconazole -